Daily Caller
‘He’s Willing To Hit Them Hard’: American Adversaries Pull Out The Stops To Derail Trump’s White House Bid
From the Daily Caller News Foundation
By Jake Smith
Former President Donald Trump dealt with some American adversaries harshly during his first term, threatening them with military action and choking their economies. Now that Trump is on the verge of being reelected, those adversaries are panicking — and trying to prevent Trump from entering the White House.
Trump is in a dead-heat race against Vice President Kamala Harris in next Tuesday’s presidential elections. Nations making up the so-called “Axis of Evil” — especially Iran and China — have made it clear they do not want Trump to win. That’s borne in part out of anger against Trump for his actions during his first term and fear of what he will do in his second, according to a review of multiple reports.
It’s an open secret that Iran and China have attempted to interfere in elections in the past, as they are this year. Both countries have utilized a variety of methods to interfere with Trump’s bid for the White House. That’s particularly true for Iran, which has attempted to kill Trump and waged cyberwarfare operations against his campaign.
“While the Islamic Republic continues to mean what it says when it calls for ‘death to America,’ there is only one current presidential contender whom the regime and its terrorist network are trying to kill. That is Donald Trump,” Behnam Ben Taleblu, a scholar on Iranian affairs at the Foundation for Defense of Democracies, told the Daily Caller News Foundation. “That is born of a clear understanding in the regime’s mind that he is the candidate of real pressure.”
Trump’s approach to Iran — the largest state sponsor of terrorism and an accomplice in the killing of scores of U.S. troops over recent years — was described by his administration as a “maximum pressure” campaign. Trump withdrew from the Obama-era Iran nuclear deal in 2018, arguing that it allowed Tehran to rake in billions of dollars under eased sanctions while failing to prevent it from building a nuclear weapon. He replaced the deal with harsh sanctions that cut off many of the country’s revenue streams.
“Trump demonstrated he’s willing to hit them hard. This isn’t the same approach we’re seeing from the current administration, which is why Iran’s focus remains on Trump,” former senior Pentagon official and Strauss Center fellow Simone Ledeen told the DCNF.
Iran’s network of terrorist groups suffered from a lack of funding as a result of Trump’s approach, but remained incredibly hostile to the U.S., launching multiple attacks on American forces in the Middle East in the following year. As attacks escalated, Trump made the decision to launch a drone strike and assassinate top Iranian general Qasem Soleimani while he was visiting Iraq in 2020.
Soleimani was a pivotal figure in the Iranian military, and his death greatly angered Tehran.
“The Soleimani strike… exposed some of Iran’s vulnerabilities,” Ledeen told the DCNF.
Iran has since staged multiple unsuccessful assassination attempts against Trump through various actors. The reports on the matter have seemed to escalate in recent months as the election draws close; U.S. intelligence officials briefed the Trump campaign in September on a previous assassination operation, which failed.
Iran has also carried out various cyberwarfare campaigns against Trump ahead of the election, some of which have been successful. Iranian-backed hackers gained access to internal Trump campaign documents — specifically regarding research about Republican vice presidential candidate J.D. Vance — and leaked it to various media outlets and reporters in August and September, only some of whom published the material.
Iranian hackers also accessed and leaked a number of internal Trump campaign emails, which made their way into public reporting. The U.S. charged three Iranian operatives for the action in late September.
“If Trump is back, I’d expect Iran to ramp up its threats,” Ledeen told the DCNF. “Another Trump term would bring renewed pressure, and Iran’s leaders know that. They’ll likely grow more desperate and aggressive as they try to hold onto control in the region, but they’re not in the position they once were.”
If Trump wins, he’ll need to be ready to face down Tehran a second time — while making it clear his contention is not with the Iranian people, who have suffered under the authoritarian Islamic regime, Taleblu told the DCNF.
“While one of the strengths of former President Trump was his ability to keep the adversary guessing, I think it’s quite clear at a minimum a future Trump administration would return to a policy of maximum pressure, and begin to put meaningful and sustained pressure on oil and petrochemical exports and financial flows,” Taleblu told the DCNF.
“What a prospective Trump administration will need to be prepared for is how Tehran might be inclined to respond to pressure with pressure of its own,” Taleblu said. “And that’s why to offset escalation by the regime, as well as to do the moral and politically astute thing, Trump will need to pair maximum pressure against the regime with a real policy of maximum support for the Iranian people.”
The Trump campaign told the DCNF that Iran is “terrified” of a second Trump presidency.
“The terror regime in Iran loves the weakness and stupidity of Kamala Harris,” spokesman Steven Cheung said.
China has also been incredibly wary of a second Trump term, according to multiple reports. Chinese officials are reportedly fearful of Trump because he appears more unpredictable than Harris.
Publicly, Beijing refuses to say who it would rather deal with. But privately, officials were previously hoping that President Joe Biden would beat out Trump in the elections because they felt Biden was less of a threat, according to officials who spoke to The Wall Street Journal earlier in October .
When Biden dropped out of the race in July, officials shifted their preference to Harris, even though neither candidate is likely that favorable to Beijing, according to the WSJ. China has expressed ire to Republican and Democratic administrations over the years and has launched cyberattack operations against both parties.
But Trump’s strict policies in particular caused headaches for officials, and they may be expecting similar policies if he wins again.
“They know a lot about what Donald Trump’s approach to government, diplomacy, trade negotiations might be, and they know a lot about what he said through the entirety of the campaign,” Steve Yates, senior fellow at the America First Policy Institute, told the DCNF. “That is a challenge to them.”
Part of the fear among Chinese officials is that Trump will launch a second trade war if reelected. During his first term, Trump imposed heavy tariffs on China, significantly raising the tax on some incoming Chinese imports and deterring Americans from buying Chinese-made goods. Trump’s goal was to balance out the U.S.-China trade relationship and compel China to buy more American goods.
Trump has already publicly mused the idea of imposing 60% tariffs on Chinese goods if he wins back the White House, something Beijing is eager to avoid.
U.S. officials have said they’ve seen evidence of China trying to interfere in this year’s elections. It was reported last week that Chinese-backed hackers targeted data on Trump’s and Vance’s phones. It wasn’t clear what, if any, information was stolen, but it could be beneficial to Beijing if anything was taken. Members of Harris’ staff were also reportedly targeted.
A spokesperson from the Chinese Embassy in the U.S. claimed that Beijing was unaware of the hacking operation.
“We cannot comment [on] it… China firmly opposes and combats cyber attacks and cyber theft in all forms,” the spokesperson said. “We hope that the U.S. side will not make accusations against China in the election.”
A number of “bot” social media accounts linked to China have also been targeting Republican congressional candidates, according to a report released last week by Microsoft’s Threat Analysis Center.
“While not always resulting in high levels of engagement, these efforts demonstrate China’s sustained attempts [to] influence U.S. politics across the board,” Clint Watts, general manager of the tech company’s agency, wrote in a post regarding the report.
From the Daily Caller News Foundation
The U.S. intercepted and seized a vessel in international waters near Venezuela, marking the second such operation in recent weeks, multiple outlets reported Saturday.
The U.S. Coast Guard led the operation with assistance from other branches of the military, U.S. officials told CNN.
The interdiction follows on the heels of the Dec. 10 seizure of a sanctioned tanker off the Venezuelan coast. It also comes just days after President Donald Trump announced a sweeping blockade on all sanctioned oil tankers arriving to or leaving the South American nation, the ruling regime of which he designated a foreign terrorist organization.
Dear Readers:
As a nonprofit, we are dependent on the generosity of our readers.
Please consider making a small donation of any amount here.
Thank you!
“The illegitimate Maduro Regime is using Oil from these stolen Oil Fields to finance themselves, Drug Terrorism, Human Trafficking, Murder, and Kidnapping,” Trump posted Tuesday on Truth Social. “I am ordering A TOTAL AND COMPLETE BLOCKADE OF ALL SANCTIONED OIL TANKERS going into, and out of, Venezuela.”
When asked following the first seizure what the U.S. would do with the confiscated oil, Trump said, “Well, we keep it, I guess.”
The operations come amid months of escalating U.S. pressure on Venezuela.
American armed forces have steadily increased their presence and operations in the southern Caribbean off Venezuela’s coast, including numerous strikes on drug smuggling vessels. The buildup has fueled speculation about a potential full-scale confrontation with Maduro or even a material push for regime change.
Trump reportedly offered Maduro a deal in late November to vacate power in exchange for safe passage for him and his family. The U.S. also placed a $50 million bounty on Maduro in August, the largest sum ever offered for a sitting head of state.
In announcing the blockade Tuesday, Trump warned the “illegitimate Maduro Regime” that the “Armada” surrounding the country “will only get bigger, and the shock to them will be like nothing they have ever seen before.” He also demanded that Maduro “return to the United States of America all of the oil, land, and other assets that they previously stole from us.”
Despite the growing pressure, Maduro dispatched two non-sanctioned vessels Thursday carrying oil to China, Reuters reported.
The Coast Guard referred questions on the operation to the White House, which did not immediately respond to the Daily Caller News Foundation’s request for comment.
Daily Caller
Ex-FDA Commissioners Against Higher Vaccine Standards Took $6 Million From COVID Vaccine Makers
From the Daily Caller News Foundation
By Emily Kopp
The FDA old guard criticized the new leadership in a Dec. 3 New England Journal of Medicine (NEJM) letter over a higher regulatory bar for vaccines, namely the expectation that most new vaccine approvals will require randomized clinical trials, arguing it could hamper the market.
“Insisting on long, expensive outcomes studies for every updated formulation would delay the arrival of better-matched vaccines when new outbreaks emerge or when additional groups of patients could benefit,” the former commissioners wrote. “Abandoning the existing methods won’t ‘elevate vaccine science’ … It will subject vaccines to a substantially higher and more subjective approval bar.”
But while the former commissioners disclosed their conflicts of interest to the medical journal — per standard practice in scientific publishing — reporters didn’t relay them to the broader public in reports in the Washington Post, STAT News and CNN.
The headlines about a bipartisan rebuke from former occupants of FDA’s highest office give the impression that the Trump administration is contravening established science, but closer inspection reveals a revolving door between pharmaceutical corporations and the agencies overseeing them.
Three of the signatories have received payments totaling $6 million from manufacturers or former manufacturers of COVID vaccines.
Scott Gottlieb has received $2.1 million in cash and stock from his position on the Pfizer board of directors, where he has advised on ethics and regulatory compliance since 2019, according to company filings to the Securities and Exchange Commission. Stephen Ostroff has received $752,310 from Pfizer in consulting fees since 2020, according to OpenPayments.
Mark McClellan has received $3.3 million from Johnson & Johnson as a member of the board of directors since 2013, SEC filings also show. McClellan also consults for the new pharmaceutical arm of the alternative investment management company Blackstone, which invested $750 million in Moderna in April 2025.
Gottlieb and McClellan did not respond to requests for comment. Ostroff could not be reached for comment.
FDA Center for Biologics Evaluation and Research Director Vinay Prasad outlined the higher standards and shared the results of an internal analysis validating 10 reports of children’s deaths following the COVID-19 vaccine in a Nov. 28 memo to staff. He called for introspection and reform at the agency.
The NEJM letter criticizes Prasad for cracking down on a practice called “immunobridging” that infers vaccine efficacy from laboratory tests rather than assessing it through real-world reductions in disease or death. The FDA under the Biden administration expanded COVID vaccines to children using this “immunobridging” technique, extrapolating vaccine efficacy from adults to children based on antibody levels.
Norman Sharpless — who in addition to previously serving as acting FDA commissioner also served as the head of the National Institutes of Health’s National Cancer Institute — consults for Tempus, a company that collaborates with COVID vaccine maker BioNTech. He has helped steer $70 million in investments in biotech through a venture capital firm he founded in November 2024. Sharpless also disclosed $26,180 in payments in 2024 from Chugai Pharmaceutical, a Japanese pharmaceutical company that markets mRNA technology among other drugs, on OpenPayments.
“I was grateful for the opportunity to serve as NCI Director and Acting FDA Commissioner in the first Trump Administration, and strongly support many of the things President Trump is trying to do in the current Administration,” Sharpless said in an email.
Margaret Hamburg, another former FDA commissioner and signatory of the NEJM letter, has since 2020 earned $2.8 million as a member of the board of Alnylam Pharmaceuticals, which markets RNA interference (RNAi) technology.
Hamburg did not respond to a message on LinkedIn.
Most signatories disclosed income from biotech companies testing experimental cancer treatments. These products could face tighter scrutiny under Prasad, a hematologist-oncologist long wary of rubberstamping pricey oncology drugs — which Prasad points out often cause some toxicity — without plausible evidence of an improvement in quality of life or survival.
The former FDA commissioners disclosed ties to Sermonix Pharmaceuticals Inc.; OncoNano Medicine; incyclix; Nucleus Radiopharma; and N-Power, a contractor that runs oncology clinical trials.
Andrew von Eschenbach, who like Sharpless formerly served both as FDA commissioner and the head of the National Cancer Institute, disclosed stock in HistoSonics, a company with investments from Bezos Expeditions and Thiel Bio seeking FDA approval for ultrasound technology targeted at tumors.
Some FDA commissioners who signed onto the letter opposing changes to vaccine approvals have ties to biotechnology investment firms, namely McClellan, who consults Arsenal Capital; Janet Woodcock, who consults RA Capital Management; and Robert Califf, who owns stock in Population Health Partners.
Califf did not respond to an email requesting comment. Woodcock did not respond to requests for comment sent to two medical research advocacy groups with Woodcock on the board. Eschenbach did not respond to a LinkedIn message.
The two signatories without pharmaceutical ties may find their judgement challenged by the FDA investigation into COVID-19 vaccine deaths, having either implemented or formally defended the Biden administration’s headlong expansion of vaccines and boosters to healthy adults and children.
David Kessler executed Biden’s vaccination policy as chief science officer at the Department of Health and Human Services, helping to secure deals for shots with Pfizer and Moderna.
Meanwhile Jane Henney chaired a National Academies of Sciences, Engineering, and Medicine report published in October 2025 that praised the performance of FDA and Centers for Disease Control and Prevention (CDC) vaccine surveillance during the pandemic — underwritten with CDC funding.
That assessment clashes with that of a Senate report, citing internal documents from FDA, finding that CDC never updated its vaccine surveillance tool “V-Safe” to include cardiac symptoms, despite naming myocarditis as a potential adverse event by October 2020, and that top officials in the Biden administration delayed warning pediatricians and other providers about the risk of myocarditis after their approval in some children in May 2021, months after Israeli health officials first detected it in February 2021. The Senate investigation named Woodcock, a signatory of the NEJM letter, as one of the FDA officials who slow-walked the warning.
Canada’s sudden rediscovery of energy ambition has been greeted with a familiar charge: hypocrisy
Paris Climate Deal Now Decade-Old Disaster
Chinese Billionaire Tried To Build US-Born Baby Empire As Overseas Elites Turn To American Surrogates
Canadian gov’t considers sharing census data on gender-confused children
Major tax changes in 2026: Report
Ottawa Pretends To Pivot But Keeps Spending Like Trudeau
Canada Lets Child-Porn Offenders Off Easy While Targeting Bible Believers
-
Business2 days agoGeopolitics no longer drives oil prices the way it used to
-
Business2 days agoArgentina’s Milei delivers results free-market critics said wouldn’t work
-
Business2 days agoDeadlocked Jury Zeroes In on Alleged US$40 Million PPE Fraud in Linda Sun PRC Influence Case
-
Censorship Industrial Complex2 days agoCanadian university censors free speech advocate who spoke out against Indigenous ‘mass grave’ hoax
-
Business22 hours agoTaxing food is like slapping a surcharge on hunger. It needs to end
-
COVID-192 days agoFreedom Convoy protester appeals after judge dismissed challenge to frozen bank accounts
-
COVID-191 day agoJudge denies Canadian gov’t request to take away Freedom Convoy leader’s truck
-
International1 day agoOttawa is still dodging the China interference threat